Lujan-Fryns syndrome

Lujan-Fryns syndrome, also known as Lujan syndrome or X-linked mental retardation with marfanoid habitus, is a rare genetic condition primarily affecting males. It is characterized by the combination of mild to moderate intellectual disability, a marfanoid body habitus (tall and thin build with long limbs and fingers), and distinctive facial features. The syndrome was first described by Lujan and colleagues in 1984 and further delineated by Fryns and colleagues. The condition affects multiple body systems. Neurological and behavioral features are prominent and include intellectual disability (typically mild to moderate), speech and language difficulties (particularly expressive language), hypotonia, and behavioral abnormalities such as hyperactivity, emotional instability, shyness, and occasionally psychotic episodes or features resembling schizophrenia. Characteristic craniofacial features include a long narrow face, prominent forehead, small mandible, high-arched or cleft palate, short philtrum, and a thin upper lip. The marfanoid habitus involves tall stature, long hands and fingers (arachnodactyly), hyperextensible joints, and a thin body build, though without the cardiovascular or ocular complications typically seen in Marfan syndrome. Lujan-Fryns syndrome is caused by mutations in the MED12 gene (also known as HOPA), located on the X chromosome (Xq13.1). This gene encodes a subunit of the Mediator complex, which plays a critical role in transcriptional regulation. There is currently no cure or specific targeted therapy for Lujan-Fryns syndrome. Management is supportive and multidisciplinary, including speech and language therapy, educational support, behavioral interventions, and psychological or psychiatric care as needed. Early intervention programs can help optimize developmental outcomes. Genetic counseling is recommended for affected families.

Common questions about Lujan-Fryns syndrome